Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Excessive glutamatergic signalling within the basal ganglia is implicated in the progression of Parkinson's disease (PD) and inthe emergence of dyskinesia associated with long-term treatment with L-DOPA. There is considerable research focus on the discovery and development of compounds that mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasparini, Fabrizio, Di Paolo, Thérèse, Gomez-Mancilla, Baltazar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703788/
https://www.ncbi.nlm.nih.gov/pubmed/23853735
http://dx.doi.org/10.1155/2013/196028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703788/
https://www.ncbi.nlm.nih.gov/pubmed/23853735
http://dx.doi.org/10.1155/2013/196028

Ejemplares similares